Keywords: antigenics, starts, pivotal, trial, vaccine, melanoma, enrolled

Antigenics starts pivotal trial of vaccine in melanoma

Article | 13 May 2002

Print This

Antigenics has enrolled the first patient in its pivotal Phase III trialof the personalized cancer vaccine Oncophage (HSPPC-96) for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in